Dachaigh › Amyloidosis Sèine Aotrom Immunoglobulin
Sgrùdaidhean clionaigeach Amyloidosis Sèine Aotrom Immunoglobulin a’ fastadh anns na SA
Tha 16 sgrùdaidhean airson Amyloidosis Sèine Aotrom Immunoglobulin a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Boston, MA7 sgrùdaidhean
- Rochester, MN5 sgrùdaidhean
- Durham, NC4 sgrùdaidhean
- New York City, NY4 sgrùdaidhean
- Columbus, OH3 sgrùdaidhean
- Cleveland, OH3 sgrùdaidhean
Le stàit
- Arizona3 sgrùdaidhean
- California3 sgrùdaidhean
- Florida3 sgrùdaidhean
- Massachusetts7 sgrùdaidhean
- Minnesota5 sgrùdaidhean
- New York4 sgrùdaidhean
- North Carolina4 sgrùdaidhean
- Ohio5 sgrùdaidhean
- Tennessee4 sgrùdaidhean
- Texas3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05898646SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07850284A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06768489Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT06569147Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT05145816A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT05951816A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Iuch 2026 · NCT07224672Teclistamab-Daratumumab in AL Amyloidosis
A’ fastadhÌre 2
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT07110844A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT07081646Registry of Older Patients With Cancer
A’ fastadhSgrùdadh amharc
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT01137825Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT06022939Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Màrt 2026 · NCT01408225Collection of Samples and Clinical Data From Patients With Amyloid Diseases
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dùbh 2025 · NCT00898235Molecular Imaging of Primary Amyloid Cardiomyopathy
A’ fastadh
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 14 Samh 2025 · NCT02641145Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 27 Dàmh 2025 · NCT01137643Screening for AL Amyloidosis in Smoldering Multiple Myeloma
A’ fastadhSgrùdadh amharc
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2025 · NCT06365060Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.